Prognostic value of the tumor-infiltrating lymphocytes in Miller-Payne grade 4 triple-negative breast cancer following neoadjuvant chemotherapy

被引：0
|
作者：
Ma, Jianli [1 ]
Deng, Yuwei [2 ]
Chen, Dawei [1 ]
Li, Xiaomei [2 ]
Yu, Zhiyong [3 ]
Wang, Haibo [4 ]
Zhong, Lei [5 ]
Li, Yingjie [5 ]
Wang, Chengqin [4 ]
Zhou, Xiaoping [2 ]
Li, Xiang [2 ]
Zhang, Qingyuan [2 ]
Yu, Jinming [1 ]
机构：
[1] Shandong Univ, Shandong Canc Hosp, Jinan, Peoples R China
[2] Harbin Med Univ, Canc Hosp, Harbin, Peoples R China
[3] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Jinan, Peoples R China
[4] Qingdao Univ, Affiliated Hosp, Qingdao, Peoples R China
[5] Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6114
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy
    Geurts, Veerle C. M.
    Balduzzi, Sara
    Steenbruggen, Tessa G.
    Linn, Sabine C.
    Siesling, Sabine
    Badve, Sunil S.
    DeMichele, Angela
    Ignatiadis, Michail
    Leon-Ferre, Roberto A.
    Goetz, Matthew P.
    Wolff, Antonio C.
    Klar, Natalie
    Michiels, Stefan
    Loi, Sherene
    Adams, Sylvia
    Horlings, Hugo M.
    Sonke, Gabe S.
    Salgado, Roberto
    Kok, Marleen
    JAMA ONCOLOGY, 2024,
  • [32] MxA expression is associated with tumor-infiltrating lymphocytes and is a prognostic factor in triple-negative breast cancer
    Young-Ae Kim
    Hee Jin Lee
    Sun-Hee Heo
    Hye Seon Park
    Suk Young Park
    WonSeon Bang
    In Hye Song
    In Ah Park
    Gyungyub Gong
    Breast Cancer Research and Treatment, 2016, 156 : 597 - 606
  • [33] MxA expression is associated with tumor-infiltrating lymphocytes and is a prognostic factor in triple-negative breast cancer
    Kim, Young-Ae
    Lee, Hee Jin
    Heo, Sun-Hee
    Park, Hye Seon
    Park, Suk Young
    Bang, WonSeon
    Song, In Hye
    Park, In Ah
    Gong, Gyungyub
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 156 (03) : 597 - 606
  • [34] Prognostic relevance of tumor-infiltrating lymphocytes in residual tumor tissue from patients with triple-negative breast cancer following neoadjuvant chemotherapy: A systematic review and meta-analysis
    Cao, Bo
    Zhang, Ziran
    Wang, Chaoxian
    Lv, Xiang
    ONCOLOGY LETTERS, 2023, 26 (04)
  • [35] Evaluation of tumor-infiltrating lymphocytes (TIL) and tumor cell apoptosis as predictive markers for response to neoadjuvant chemotherapy in triple-negative breast cancer
    Ono, M.
    Tsuda, H.
    Shimizu, C.
    Yamamoto, S.
    Shibata, T.
    Kouno, T.
    Tamura, K.
    Ando, M.
    Katsumata, N.
    KInoshita, T.
    Fujiwara, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [36] Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis
    Gao, Guoxuan
    Wang, Zihan
    Qu, Xiang
    Zhang, Zhongtao
    BMC CANCER, 2020, 20 (01)
  • [37] Changes in Tumor-infiltrating Lymphocytes After Neoadjuvant Chemotherapy and Clinical Significance in Triple Negative Breast Cancer
    Lee, Hyun
    Lee, Miseon
    Seo, Jeong-Han
    Gong, Gyungyub
    Lee, Hee Jin
    ANTICANCER RESEARCH, 2020, 40 (04) : 1883 - 1890
  • [38] Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis
    Guoxuan Gao
    Zihan Wang
    Xiang Qu
    Zhongtao Zhang
    BMC Cancer, 20
  • [39] Tumor-infiltrating lymphocytes in triple negative breast cancer
    Zakhartseva, L. M.
    Yanovytska, M. O.
    PATHOLOGIA, 2020, (03): : 287 - 294
  • [40] A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer
    Criscitiello, C.
    Bayar, M. A.
    Curigliano, G.
    Symmans, F. W.
    Desmedt, C.
    Bonnefoi, H.
    Sinn, B.
    Pruneri, G.
    Vicier, C.
    Pierga, J. Y.
    Denkert, C.
    Loibl, S.
    Sotiriou, C.
    Michiels, S.
    Andre, F.
    ANNALS OF ONCOLOGY, 2018, 29 (01) : 162 - 169
12345